Use of pegfilgrastim primary prophylaxis and risk of infection, by chemotherapy cycle and regimen, among patients with breast cancer or non-Hodgkin’s lymphoma.
Purpose This study aims to examine granulocyte colony-stimulating factor (G-CSF) prophylaxis by cancer type, chemotherapy regimen, and cycle in a real-world setting to assess if practice conforms to clinical guidelines, which recommend G-CSF prophylaxis every cycle when a patient’s risk of febrile n...
| Published in: | Supportive Care in Cancer Vol. 22; no. 8; pp. 2167 - 2176 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
Aug2014
|
| Online Access: | View this record in EBSCOhost |